These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24846021)

  • 1. FDA warns against procedure used in removing fibroids.
    Stephenson J
    JAMA; 2014 May; 311(19):1956. PubMed ID: 24846021
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of morcellation to remove fibroids scrutinized at FDA hearings.
    Hampton T
    JAMA; 2014 Aug; 312(6):588. PubMed ID: 25117116
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA warns against power morcellation for hysterectomy and fibroids.
    Wallis L
    Am J Nurs; 2014 Jul; 114(7):16. PubMed ID: 25742335
    [No Abstract]   [Full Text] [Related]  

  • 4. Morcellation and myomas: Balancing decisions around minimally invasive treatments for fibroids.
    Siedhoff MT; Kim KH
    J Surg Oncol; 2015 Dec; 112(7):769-71. PubMed ID: 26768314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA considers restricting or banning laparoscopic morcellation.
    Brower V
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25313228
    [No Abstract]   [Full Text] [Related]  

  • 6. US agency warns against morcellation in hysterectomies and myomectomies.
    McCarthy M
    BMJ; 2014 Apr; 348():g2872. PubMed ID: 24755656
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reflections about the impact caused by the Food and Drug Administration (FDA) warning against uterine and/or fibroid power morcellation].
    Brito LG; Rosa e Silva JC; Nogueira AA
    Rev Bras Ginecol Obstet; 2015 Jul; 37(7):299-301. PubMed ID: 26247248
    [No Abstract]   [Full Text] [Related]  

  • 8. AAGL advancing minimally invasive gynecology worldwide: statement to the FDA on power morcellation.
    Brown J
    J Minim Invasive Gynecol; 2014; 21(6):970-1. PubMed ID: 25195157
    [No Abstract]   [Full Text] [Related]  

  • 9. N-of-1 Policymaking--Tragedy, Trade-offs, and the Demise of Morcellation.
    Rosenbaum L
    N Engl J Med; 2016 Mar; 374(10):986-90. PubMed ID: 26962735
    [No Abstract]   [Full Text] [Related]  

  • 10. The Morcellation Debate: The History and the Science.
    Adelman MR
    Clin Obstet Gynecol; 2015 Dec; 58(4):710-7. PubMed ID: 26512438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based estimates of the prevalence of uterine sarcoma among patients with leiomyomata undergoing surgical treatment.
    Mao J; Pfeifer S; Zheng XE; Schlegel P; Sedrakyan A
    JAMA Surg; 2015 Apr; 150(4):368-70. PubMed ID: 25650751
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluating the risks of electric uterine morcellation.
    Kho KA; Nezhat CH
    JAMA; 2014 Mar; 311(9):905-6. PubMed ID: 24504415
    [No Abstract]   [Full Text] [Related]  

  • 13. Parasitic leiomyomas after laparoscopic surgery with morcellation.
    Leren V; Langebrekke A; Qvigstad E
    Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1233-6. PubMed ID: 22574911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic surgery on broken points for uterine sarcoma in the early stage decrease prognosis.
    Liu H; Zhu Y; Zhang GN; Wang C; Li C; Shi Y
    Sci Rep; 2016 Aug; 6():31229. PubMed ID: 27503773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The limits of laparoscopic myomectomy. Gynecol Obstet Fertil 2005;33:44-9].
    Dubuisson JB
    Gynecol Obstet Fertil; 2005; 33(7-8):553-4. PubMed ID: 16005665
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA likely to further restrict or ban morcellation.
    Brower V
    Lancet Oncol; 2014 Aug; 15(9):e369. PubMed ID: 25225696
    [No Abstract]   [Full Text] [Related]  

  • 17. A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma.
    Gao Z; Li L; Meng Y
    PLoS One; 2016; 11(2):e0148050. PubMed ID: 26828206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myomectomy for uterine myomas through ultramini-laparotomy.
    Wen KC; Sung PL; Lee WL; Li YT; Su WH; Wang PH
    J Obstet Gynaecol Res; 2011 May; 37(5):383-92. PubMed ID: 21272149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in surgical technique after FDA statement on power morcellation.
    Desai VB; Guo XM; Xu X
    Am J Obstet Gynecol; 2015 May; 212(5):685-7. PubMed ID: 25735888
    [No Abstract]   [Full Text] [Related]  

  • 20. Fertility-sparing approach in a teenager with uterine tumor diagnosed as a sarcoma on imaging.
    Berveiller P; Mir O; Menu Y; Jamali M; Carbonne B
    Gynecol Obstet Invest; 2010; 69(3):157-9. PubMed ID: 20016187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.